MOH vs. HUM, CNC, UNH, ELV, CI, OSCR, ALHC, TRUP, CLOV, and NEUE
Should you be buying Molina Healthcare stock or one of its competitors? The main competitors of Molina Healthcare include Humana (HUM), Centene (CNC), UnitedHealth Group (UNH), Elevance Health (ELV), The Cigna Group (CI), Oscar Health (OSCR), Alignment Healthcare (ALHC), Trupanion (TRUP), Clover Health Investments (CLOV), and NeueHealth (NEUE). These companies are all part of the "hospital & medical service plans" industry.
Humana (NYSE:HUM) and Molina Healthcare (NYSE:MOH) are both large-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, valuation, community ranking, profitability, analyst recommendations, earnings and dividends.
92.4% of Humana shares are held by institutional investors. Comparatively, 98.5% of Molina Healthcare shares are held by institutional investors. 0.3% of Humana shares are held by company insiders. Comparatively, 1.1% of Molina Healthcare shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Humana currently has a consensus target price of $423.63, indicating a potential upside of 21.10%. Molina Healthcare has a consensus target price of $407.45, indicating a potential upside of 31.20%. Given Humana's stronger consensus rating and higher probable upside, analysts clearly believe Molina Healthcare is more favorable than Humana.
Humana has higher revenue and earnings than Molina Healthcare. Molina Healthcare is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.
Humana has a beta of 0.5, meaning that its share price is 50% less volatile than the S&P 500. Comparatively, Molina Healthcare has a beta of 0.54, meaning that its share price is 46% less volatile than the S&P 500.
Humana received 355 more outperform votes than Molina Healthcare when rated by MarketBeat users. Likewise, 64.06% of users gave Humana an outperform vote while only 57.00% of users gave Molina Healthcare an outperform vote.
Molina Healthcare has a net margin of 2.99% compared to Molina Healthcare's net margin of 1.82%. Humana's return on equity of 29.86% beat Molina Healthcare's return on equity.
In the previous week, Molina Healthcare had 2 more articles in the media than Humana. MarketBeat recorded 17 mentions for Molina Healthcare and 15 mentions for Humana. Molina Healthcare's average media sentiment score of 0.74 beat Humana's score of 0.46 indicating that Humana is being referred to more favorably in the media.
Summary
Molina Healthcare beats Humana on 11 of the 18 factors compared between the two stocks.
Get Molina Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for MOH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MOH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Molina Healthcare Competitors List
Related Companies and Tools
